N6-methyladenosine RNA modification in melanoma progression and immunotherapy

N6-methyladenosine (m6A) is the most prevalent internal modification of eukaryotic messenger RNA and has emerged as a major post-transcriptional regulator of cancer biology. In melanoma, dysregulated m6A deposition, removal, and recognition influence tumor-cell proliferation, phenotypic plasticity, invasion, metastatic competence, metabolic adaptation, and immune escape. Mechanistic studies have identified context-dependent functions of the METTL3–METTL14 methyltransferase complex, the demethylases FTO and ALKBH5, and reader proteins including YTHDF family members and IGF2BPs. These regulators also shape antitumor immunity by altering interferon signaling, antigen presentation, lactate metabolism, immune-cell infiltration, and sensitivity to immune-checkpoint blockade. In parallel, transcriptomic studies have generated m6A-related molecular subtypes and risk scores associated with prognosis and immunotherapy response, although their clinical utility remains unproven. Pharmacologic targeting of METTL3, FTO, ALKBH5, and m6A-dependent reader pathways provides a developing therapeutic framework, but selectivity, delivery, and cell-type specificity remain major challenges. This review synthesizes current evidence linking m6A regulation to melanoma progression, immune remodeling, biomarker development, and therapeutic intervention, while defining key evidence gaps that must be addressed before clinical translation can be achieved.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-18
DOI
https://doi.org/10.3389/fcell.2026.1960928
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

N6-methyladenosine RNA modification in melanoma progression and immunotherapy

耿耘, Wenlong Zhu, Hui Xu, YUYUN XIONG et al.
1 links
Frontiers in Cell and Developmental Biology
RNA modifications and cancer
article

N6-methyladenosine RNA modification in melanoma progression and immunotherapy

耿耘, Wenlong Zhu, Hui Xu, YUYUN XIONG, Yunwen Zheng, Xiaoyue Wan, Yi Li, Yumei Li
article en

Abstract

N6-methyladenosine (m6A) is the most prevalent internal modification of eukaryotic messenger RNA and has emerged as a major post-transcriptional regulator of cancer biology. In melanoma, dysregulated m6A deposition, removal, and recognition influence tumor-cell proliferation, phenotypic plasticity, invasion, metastatic competence, metabolic adaptation, and immune escape. Mechanistic studies have identified context-dependent functions of the METTL3–METTL14 methyltransferase complex, the demethylases FTO and ALKBH5, and reader proteins including YTHDF family members and IGF2BPs. These regulators also shape antitumor immunity by altering interferon signaling, antigen presentation, lactate metabolism, immune-cell infiltration, and sensitivity to immune-checkpoint blockade. In parallel, transcriptomic studies have generated m6A-related molecular subtypes and risk scores associated with prognosis and immunotherapy response, although their clinical utility remains unproven. Pharmacologic targeting of METTL3, FTO, ALKBH5, and m6A-dependent reader pathways provides a developing therapeutic framework, but selectivity, delivery, and cell-type specificity remain major challenges. This review synthesizes current evidence linking m6A regulation to melanoma progression, immune remodeling, biomarker development, and therapeutic intervention, while defining key evidence gaps that must be addressed before clinical translation can be achieved.

Frontiers in Cell and Developmental BiologyVol. 14
Jiangsu University (CN), Tokyo University of Science (JP), Affiliated Hospital of Jiangsu University (CN), Wuyi University (CN), Institute of Medical Science, The University of Tokyo (JP), The University of Tokyo (JP), Wuyi University (CN)
Good health and well-being
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon